OxSonics Limited Nominated & Shortlisted For “Best New Medtech Development Programme” Award

Oxford, UK – 21 August 2014 – OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it has been nominated and shortlisted as a finalist in the national OBN awards in the category of “Best New Medtech Development Programme”. OxSonics was established in July 2013 […]

OxSonics Limited Secures £2.1m Biomedical Catalyst Award

Oxford, UK – 16 June 2014 OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, today announced it has successfully secured a major £2.1 million Biomedical Catalyst award from the UK’s innovation agency, the Technology Strategy Board. OxSonics was established in July 2013 to develop and commercialise […]

OxSonics Limited Completes Series A Equity Financing

Oxford, UK – 17 January 2014 OxSonics Limited (“OxSonics”), a University of Oxford spin-out company developing a new generation of ultrasound-based medical devices, closes a series A equity financing of £2.7 million. OxSonics was established in July 2013 to develop and commercialise a range of medical devices including “SonoTran”, an innovative drug delivery platform. SonoTran […]